Editorial: Exploring Maternal-Fetal Pharmacology Through PBPK Modeling Approaches

• André Dallmann,
• John N. van den Anker,
• John N. van den Anker

Affiliations

André Dallmann

Pharmacometrics/Modeling and Simulation, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany

John N. van den Anker

Division of Clinical Pharmacology, Children's National Hospital, Washington, DC, United States

John N. van den Anker

Department of Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland